Substance Abuse Self-Help Group Referral: Outcomes and Services Use

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00105729
First received: March 16, 2005
Last updated: January 24, 2013
Last verified: September 2006
  Purpose

Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.


Condition Intervention
Substance Use Disorders
Behavioral: Intensive referral to 12-step self-help groups

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Substance Abuse Self-Help Group Referral: Outcome and Services Use

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • DRUG USE AND ALCOHOL USE AT 6 MONTHS AND 1 YEAR [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • SUBSTANCE ABUSE AND PSYCHIATRIC SERVICES USE AT 6 MONTHS AND 1 YEAR [ Designated as safety issue: No ]

Estimated Enrollment: 345
Study Start Date: January 2003
Study Completion Date: April 2005
Arms Assigned Interventions
Arm 1 Behavioral: Intensive referral to 12-step self-help groups

Detailed Description:

Background:

Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.

Objectives:

The first objective was to implement and validate procedures to help counselors make effective referrals to SHGs for SUD patients. This project randomly assigned SUD outpatients to a standard referral or an intensive referral condition. We are determining the extent to which intensive referral increased patients' SHG attendance and involvement in comparison to standard referral. The second objective is to determine whether patients who received intensive referral to SHGs have better substance use and functioning outcomes over the 1-year follow-up period, and less use of formal treatment services, thereby reducing costs for VA, than those who received standard referral. The long-term goal is to develop and implement guidelines to facilitate SUD patients' participation in SHGs and thereby improve their quality of life and decrease their use of VA's specialized SUD treatment services.

Methods:

This project used a randomized design in which 345 patients entering VA outpatient SUD treatment were randomly assigned to either standard or intensive referral to SHGs. Standard referral consisted of the counselor recommending SHG participation. The keys to intensive referral included the counselor facilitating direct contact between the patient and a member of the SHG, and counselor follow-up on the recommendation for self-help. Patients were followed at 6 months and 1 year to determine whether intensive referral resulted in more self-help attendance and involvement; in better substance use and functioning outcomes (using the Addiction Severity Index); and in less use of VA services and lower treatment costs (using methods of the VA Health Economics Resource Center). To make these determinations, we are conducting analyses at each follow-up, and then will use hierarchical linear modeling to examine the benefits of intensive referral over time.

Status:

Project work is ongoing.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Consecutive substance use disorder outpatients at VA PA HCS and is not cognitively impaired.

Exclusion Criteria:

Cognitive impairment

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00105729

Sponsors and Collaborators
Investigators
Principal Investigator: Christine Timko, PhD VA Palo Alto Health Care System
  More Information

Publications:
Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00105729     History of Changes
Other Study ID Numbers: IIR 20-067
Study First Received: March 16, 2005
Last Updated: January 24, 2013
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Self-help groups
Referral and consultation

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on October 23, 2014